The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days
Winlevi is authorized in EU for the treatment of acne vulgaris
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
